Lena Hagman
Fortune : 137 555 $ au 31/08/2026
Fortune : 137 555 $ au 31/08/2026
Lena Hagman currently works at Xvivo Perfusion AB, as Chief Operating Officer & Deputy CEO from 2024.
Ms. Hagman also formerly worked at Neoventa Medical AB, as Operations Director and Getinge AB, as Executive Vice President-Quality Regulatory from 2020 to 2022.
Ms. Hagman received her undergraduate degree from Chalmers University of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,02 % | 31/12/2025 | 5 000 ( 0,02 % ) | 137 555 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| XVIVO PERFUSION AB | Directeur des opérations | 01/12/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| GETINGE AB | Compliance Officer | 01/10/2020 |
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Provides fetal monitoring solutions and obstetric care services | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Getinge AB
Getinge AB Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and disinfectants | Health Technology |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Provides fetal monitoring solutions and obstetric care services | Health Technology |
Xvivo Perfusion AB
Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national